Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs Oracle Corporation (ORCL) Price & Performance

Acadia Healthcare Company IncTrade
Oracle CorporationTrade

Price performance (Past 24H)

Key statistics

Acadia Healthcare Company Inc vs Oracle Corporation — how do they compare? Acadia Healthcare Company Inc trades at $31.14 (market cap $2.90B), while Oracle Corporation trades at $150.38 (market cap $419.05B). The key difference: Oracle Corporation is far larger — about 144.5× Acadia Healthcare Company Inc's market cap, and Oracle Corporation pays a 1.37% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.

ACHCORCL
Market Cap
$2.90B$419.05B
Sector
HealthTechnology
52-Week High
$35.61$328.33
52-Week Low
$11.68$114.99
Enterprise Value
$5.29B$548.30B
Dividend Yield
1.37%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.14, down 2.01% today, with a neutral technical signal and mixed fundamentals. The company reported Q2 2026 EPS of $0.38, beating estimates, but maintains a net loss of -$1.10B for 2025. Analyst consensus is bullish with a $36.00 price target, though ongoing legal investigations and negative profit margins present headwinds. Cash flow from operations improved to $211M in 2026, supporting operational stability amid challenges.

The outlook for ACHC hinges on execution of its turnaround strategy and resolution of legal issues. Upside potential exists if EBITDA guidance improvements and admissions growth persist, but risks from litigation and sustained losses warrant caution. The stock's current valuation at a P/E of 19.82 and P/S of 0.84 may attract value investors if profitability recovers.

Oracle Corporation

Oracle Corporation (ORCL) trades at $151.04, up 2.79% with strong technical momentum. The stock shows robust fundamentals with 21.67% net profit margin and consistent earnings beats in recent quarters. Oracle's AI infrastructure positioning and partnership with OpenAI have driven investor optimism, though RSI levels suggest potential overbought conditions. The company maintains solid cash flow generation with $20.82B from operations in 2025.

Oracle presents a compelling growth story with AI-driven revenue acceleration and strong analyst support (65% buy ratings). Key risks include high valuation multiples and significant debt load. The consensus price target of $252.44 implies substantial upside, but investors should monitor execution on AI investments and competitive pressures in cloud infrastructure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.

Read more on ORCL